CVR Medical Corp. (CRRVF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CVR Medical Corp. (CRRVF) with AI Score 45/100 (Weak). CVR Medical Corp. focuses on developing a diagnostic tool for carotid arterial stenosis using sound wave analysis technology. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026CVR Medical Corp. (CRRVF) Healthcare & Pipeline Overview
CVR Medical Corp. is a healthcare company focused on the research and development of sound wave analysis technology for medical diagnostics, specifically a carotid stenotic scan device. Targeting patients, payors, and healthcare providers, CVR operates in the medical devices sector, striving to improve carotid arterial stenosis detection.
Investment Thesis
CVR Medical Corp. presents a speculative investment opportunity within the medical device sector, driven by its proprietary carotid stenotic scan device. The company's focus on sound wave analysis technology offers a potentially non-invasive and cost-effective solution for detecting carotid arterial stenosis. Key value drivers include successful clinical validation of the device, regulatory approvals, and strategic partnerships for commercialization. The current market capitalization of $0.00B reflects the early stage of the company and the inherent risks associated with medical device development. Upcoming catalysts include the completion of clinical trials and potential FDA clearance. However, investors should be aware of the significant risks, including the need for additional funding, competition from established diagnostic methods, and the uncertainty of regulatory approval. The high beta of 1.91 indicates significant volatility, making this investment suitable only for risk-tolerant investors.
Based on FMP financials and quantitative analysis
Key Highlights
- CVR Medical Corp. is focused on developing a non-invasive diagnostic tool for carotid arterial stenosis using sound wave analysis.
- The company's primary product is the carotid stenotic scan device, targeting patients, payors, and healthcare providers.
- Incorporated in 1980, CVR Medical Corp. has a long history of research and development in the medical device sector.
- The company operates in the medical devices industry, which is characterized by rapid technological advancements and stringent regulatory requirements.
- CVR Medical Corp. has a market capitalization of $0.00B, reflecting its early stage and high-risk profile.
Competitors & Peers
Strengths
- Proprietary sound wave analysis technology.
- Potential for non-invasive and cost-effective diagnostic solution.
- Focus on early detection of carotid arterial stenosis.
- Experienced management team with expertise in medical device development.
Weaknesses
- Limited financial resources and market presence.
- Reliance on a single product (carotid stenotic scan device).
- Lack of established distribution channels.
- Uncertainty regarding regulatory approvals.
Catalysts
- Upcoming: Completion of clinical trials for the carotid stenotic scan device.
- Upcoming: Potential FDA clearance or other regulatory approvals.
- Ongoing: Strategic partnerships with healthcare providers for commercialization.
- Ongoing: Continued research and development efforts to improve the technology.
Risks
- Potential: Need for additional funding to support operations and clinical trials.
- Potential: Competition from established diagnostic methods (ultrasound, angiography, MRI).
- Potential: Uncertainty regarding regulatory approvals.
- Ongoing: Technological obsolescence.
- Ongoing: Product liability risks.
Growth Opportunities
- Expansion into New Geographic Markets: CVR Medical Corp. has the opportunity to expand its market reach beyond North America by targeting regions with a high prevalence of cardiovascular diseases, such as Europe and Asia. The global market for carotid stenosis diagnostics is estimated to be worth several billion dollars, providing a significant opportunity for revenue growth. Timeline: 2-3 years.
- Strategic Partnerships with Healthcare Providers: Forming strategic alliances with hospitals, clinics, and diagnostic centers can accelerate the adoption of CVR Medical's carotid stenotic scan device. These partnerships can provide access to a large patient base and facilitate the integration of the device into existing clinical workflows. The market for diagnostic services is substantial, with healthcare providers continuously seeking innovative solutions to improve patient care. Timeline: 1-2 years.
- Development of New Applications for Sound Wave Technology: CVR Medical can leverage its expertise in sound wave analysis to develop new diagnostic tools for other cardiovascular conditions, such as peripheral artery disease and coronary artery disease. This diversification can broaden the company's product portfolio and reduce its reliance on a single product. The market for cardiovascular diagnostics is constantly evolving, with a growing demand for non-invasive and accurate diagnostic methods. Timeline: 3-5 years.
- Securing Regulatory Approvals in Key Markets: Obtaining regulatory approvals from bodies like the FDA in the United States and the CE mark in Europe is crucial for the commercial success of CVR Medical's carotid stenotic scan device. These approvals will validate the safety and efficacy of the device and enable its widespread adoption by healthcare providers. The regulatory pathway for medical devices is rigorous, but successful navigation can unlock significant market opportunities. Timeline: Ongoing.
- Integration with Telemedicine Platforms: Integrating CVR Medical's diagnostic technology with telemedicine platforms can expand its reach to remote and underserved populations. This integration can enable remote monitoring of patients at risk of carotid stenosis and facilitate timely intervention. The telemedicine market is experiencing rapid growth, driven by the increasing adoption of digital health technologies and the need for remote healthcare solutions. Timeline: 2-3 years.
Opportunities
- Expansion into new geographic markets.
- Strategic partnerships with healthcare providers.
- Development of new applications for sound wave technology.
- Integration with telemedicine platforms.
Threats
- Competition from established diagnostic methods (ultrasound, angiography, MRI).
- Technological obsolescence.
- Stringent regulatory requirements.
- Product liability risks.
Competitive Advantages
- Proprietary sound wave analysis technology.
- Potential for non-invasive and cost-effective diagnostic solution.
- Early mover advantage in the application of sound wave technology for carotid stenosis detection.
- Intellectual property protection through patents.
About CRRVF
CVR Medical Corp., incorporated in 1980 and headquartered in North Vancouver, Canada, is a healthcare company dedicated to the research and development of innovative diagnostic technologies. The company specializes in using subsonic, infrasonic, and low-frequency sound wave analysis for medical applications. Its primary product is the carotid stenotic scan device, a non-invasive diagnostic tool designed to detect and measure carotid arterial stenosis, a narrowing of the carotid arteries that can lead to stroke. CVR Medical aims to provide a cost-effective and accurate solution for early detection of this condition. The company targets a broad range of stakeholders, including patients seeking proactive health monitoring, payors looking for efficient diagnostic solutions, and healthcare providers aiming to improve patient outcomes. CVR Medical's focus on sound wave technology distinguishes it within the medical device landscape, positioning it as a potential disruptor in the carotid stenosis diagnostic market. The company continues to refine its technology and explore potential applications in other areas of medical diagnostics, driven by a commitment to innovation and improved patient care.
What They Do
- Researches and develops sound wave analysis technology for healthcare applications.
- Focuses on non-invasive diagnostic tools.
- Provides a carotid stenotic scan device for detecting carotid arterial stenosis.
- Targets patients seeking proactive health monitoring.
- Offers solutions for payors looking for efficient diagnostic methods.
- Aids healthcare providers in improving patient outcomes through early detection.
Business Model
- Develops and commercializes the carotid stenotic scan device.
- Generates revenue through the sale of the diagnostic device.
- Potentially generates revenue through service contracts and maintenance agreements.
- May explore licensing agreements for its technology.
Industry Context
CVR Medical Corp. operates within the medical device industry, a sector characterized by continuous innovation and stringent regulatory oversight. The market for carotid stenosis diagnostics is driven by the increasing prevalence of cardiovascular diseases and the need for early detection to prevent strokes. Competitors include companies offering traditional imaging techniques like ultrasound, angiography, and MRI. CVR Medical aims to differentiate itself with its non-invasive sound wave technology. The industry is subject to regulatory approvals from bodies like the FDA, which can significantly impact the time-to-market for new devices. The global medical devices market is projected to reach $600 billion by 2026, indicating substantial growth potential.
Key Customers
- Patients at risk of carotid arterial stenosis.
- Payors, including insurance companies and healthcare systems.
- Healthcare providers, such as hospitals, clinics, and diagnostic centers.
Financials
Chart & Info
CVR Medical Corp. (CRRVF) stock price: Price data unavailable
Latest News
No recent news available for CRRVF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRRVF.
Price Targets
Wall Street price target analysis for CRRVF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CRRVF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Darren Day
CEO
Darren Day is the Chief Executive Officer of CVR Medical Corp. His background includes experience in corporate management and strategic development within the healthcare sector. He has been involved in guiding the company through its research and development phases, focusing on the commercialization of the carotid stenotic scan device. His expertise lies in navigating the regulatory landscape and securing partnerships to advance the company's goals.
Track Record: Under Darren Day's leadership, CVR Medical Corp. has focused on advancing the development and validation of its carotid stenotic scan device. Key milestones include securing funding for clinical trials and initiating partnerships with research institutions. He has also overseen the company's efforts to obtain regulatory approvals for its technology.
CRRVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that CVR Medical Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies on this tier may have limited financial disclosures and may not be subject to the same level of scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and requires increased due diligence from investors. Unlike NYSE/NASDAQ listings, OTC Other stocks often have less stringent listing requirements, resulting in a wider range of company quality.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier listing.
- Potential for low trading volume and price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited regulatory oversight and investor protection.
- Difficulty in obtaining accurate and timely information about the company.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Company has been in operation since 1980.
- Focus on research and development of medical device technology.
- Patents or intellectual property related to its technology.
- Partnerships with research institutions or healthcare providers.
- CEO with relevant experience in the healthcare sector.
What Investors Ask About CVR Medical Corp. (CRRVF)
What does CVR Medical Corp. do?
CVR Medical Corp. is a healthcare company focused on the research, development, and commercialization of a non-invasive diagnostic tool for carotid arterial stenosis. Their primary product, the carotid stenotic scan device, utilizes sound wave analysis technology to detect and measure the narrowing of carotid arteries, a condition that can lead to stroke. The company aims to provide a cost-effective and accurate solution for early detection, targeting patients, payors, and healthcare providers.
What do analysts say about CRRVF stock?
As of 2026-03-17, there is no readily available analyst coverage for CRRVF due to its OTC listing and small market capitalization. Investment decisions should be based on individual risk tolerance and thorough due diligence, considering the speculative nature of the company and its reliance on the successful development and commercialization of its carotid stenotic scan device. Key valuation metrics are currently unavailable, and growth considerations are tied to regulatory approvals and market adoption.
What are the main risks for CRRVF?
The main risks for CVR Medical Corp. include the need for additional funding to support ongoing research and development, clinical trials, and commercialization efforts. Competition from established diagnostic methods, such as ultrasound and angiography, poses a significant challenge. Regulatory approvals are uncertain and can be lengthy and costly. The company's reliance on a single product increases its vulnerability to technological obsolescence and market changes. Product liability risks are inherent in the medical device industry.
What are the key factors to evaluate for CRRVF?
CVR Medical Corp. (CRRVF) currently holds an AI score of 45/100, indicating low score. Key strength: Proprietary sound wave analysis technology.. Primary risk to monitor: Potential: Need for additional funding to support operations and clinical trials.. This is not financial advice.
How frequently does CRRVF data refresh on this page?
CRRVF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CRRVF's recent stock price performance?
Recent price movement in CVR Medical Corp. (CRRVF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary sound wave analysis technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CRRVF overvalued or undervalued right now?
Determining whether CVR Medical Corp. (CRRVF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CRRVF?
Before investing in CVR Medical Corp. (CRRVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be limited due to the company's OTC listing.
- AI analysis is pending and may provide further insights.